Here are three insights:
1. The merger between the two drug companies is valued at $160 billion and is the largest of its kind to date.
2. The Treasury Department implemented strict new rules on tax inversions, which many view as a way to block the Pfizer-Allergan merger.
3. Pfizer opted to move its tax addresses to Dublin to save billions in tax revenues, resulting in political scrutiny from candidates including Hillary Clinton and Donald Trump.
More articles on quality & infection control:
Consumers don’t link prices with quality — 4 key points
Should medical professionals use body cameras? 4 notes
Quality problems surround Theranos’ medical testing — 5 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.